Phase II Open-Label, Non-Randomized, Multicenter Study of Interstitial 131I-chTNT-1/B for the Treatment of Newly Diagnosed or Recurrent Malignant Glioma.
Phase of Trial: Phase II
Latest Information Update: 23 May 2011
At a glance
- Drugs Iodine I 131 derlotuximab biotin (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Therapeutic Use
- 11 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 02 Oct 2005 New trial record.